Charles Chen, Cinthya Aguero, Alexandra Melloni, Emma Thibault, Jessie Fanglu Fu, Michelle Farrell, Stephanie Schultz, and Jean‐Pierre Bellier have nothing to disclose. Brian Healy received funding from Novartis and Genzyme. Hyun‐Sik Yang received consulting fees from Axon Advisors. Jasmeer Chhatwal received consulting fees from ExpertConnect and MedaCorp. Pia Kivisäkk Webb and Steven Arnold are named as co‐inventor on a US patent application related to neurological biomarker assays that is jointly held by Massachusetts General Hospital and Meso Scale Diagnostics. Steven Arnold received funding from Abbvie, AC Immune, Alzheimer's Association, Athira, Challenger Foundation, Novartis, Seer Biosciences, Venture Wall, Chromadex, Ionis Pharmaceuticals, Janessen Pharmaceuticals, John Sperling Foundation, Gatehouse Bio, Eli Lilly/Fortrea, and Superfluid Dx; consulting fees from Allyx Therapeutics, BioVie, Bob's Last Marathon, and Merck; and payment for expert testimony from Foster & Eldredge and ProSelect Insurance Co. Dana Penney and Randall Davis are co‐inventors on US patents related to the digital Clock Drawing Test assessment that are owned by MIT and Lahey Clinic and licensed by Linus Health. Dorene Rentz received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from American Association for the Advancement of Science (AAAS) Judicial Seminar, Northwestern University T32 keynote address, and UC Irvine Distinguished Lecture Series; support for attending meetings and/or travel from Alzheimer's Clinical Trials Consortium (ACTC); participation on a Data Safety Monitoring Board or Advisory Board from Scientific Advisory Boards WashU Connectome Project and UC Davis Alzheimer's Disease Research Center (ADRC); leadership or fiduciary role in other board, society committee, or advocacy groups from Alzheimer's Association Cognitive Workgroup (unpaid) and Alzheimer's Association Clinical Meaningfulness Workgroup (unpaid). Teresa Gomez‐Isla received funding from CureAlz Fund grant, AbbVIE, and Siemens; support for attending meetings and/or travel from Fundacion Achucarro and Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED); participation on a Data Safety Monitoring Board or Advisory Board from Mindimmune and ACAD University of Pennsylvania; and other financial interests from AbbVIE and Siemens. Reisa Sperling received support from Alzheimer's Association, GHR Foundation, Eli Lilly, and Eisai; consulting fees from AbbVie, AC Immune, Acumen, Alector, Apellis, Biohaven, Bristol Myers Squibb, Genetech, Janssen, Nervgen, Oligomerix, Prothena, Roche, Vigil Neuroscience, Ionis, and Vaxxinity; and support for attending meetings and/or travel from Alzheimer's Association, Clinical Trials in Alzheimer's Disease, and Janssen. Keith Johnson received support from Alzheimer's Association, GHR Foundation, Eli Lilly, and Eisai; and consulting fees from Novartis, Merck, and Janssen. Julie Price received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from University of Michigan and AdventHealth Translational Research Inst.; support for attending meetings and/or travel from PET Pharmacokinetics (PK) Course and Brain PET conference; participation on a Data Safety Monitoring Board or Advisory Board from University of Pennsylvania; and leadership or fiduciary role in other board, society, committee or advocacy groups from Human Amyloid Imaging Meeting (unpaid), Alzheimer's Association (unpaid), and Society of Nuclear Medicine and Molecular Imaging (SNMMI) (unpaid). Any author disclosures are available in the Supporting Information.
PubMed
